Press Releases Events & Presentations Press Releases Year None2019201820172016201520142013201220112010 Aug 09, 2019 Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) View HTML PDF Version Aug 07, 2019 Assembly Biosciences Announces Appointment of John McHutchison, AO, MD, as President and Chief Executive Officer View HTML PDF Version Aug 05, 2019 Assembly Biosciences Reports Second Quarter 2019 Financial Results and Recent Highlights View HTML PDF Version Jun 27, 2019 Assembly Biosciences Announces First Patient Dosed with ABI-M201 in Phase 1b Clinical Trial for Mildly to Moderately Active Ulcerative Colitis View HTML PDF Version Jun 25, 2019 Assembly Biosciences Announces Participation in the Microbiome Movement Drug Development Summit View HTML PDF Version Jun 21, 2019 Assembly Biosciences Announces Presentation at International Association for the Study of the Liver Congress and Update on HBV Program in China View HTML PDF Version May 09, 2019 Assembly Biosciences Reports First Quarter 2019 Financial Results and Recent Highlights View HTML PDF Version May 02, 2019 Assembly Biosciences Announces Changes to Senior Leadership Team View HTML PDF Version Apr 22, 2019 Development Veteran Steven J. Knox Joins Assembly Biosciences as Senior Vice President, Clinical Development View HTML PDF Version Apr 13, 2019 Assembly Biosciences Presents Interim Data from Two Phase 2a Studies of ABI-H0731 in HBV-Infected Subjects in a Late-Breaker Oral Session at EASL 2019 View HTML PDF Version Pagination Current page 1 Page 2 Next page next › Last page last » Shareholder Tools Print Email Alerts Printed Materials RSS News Feeds Search Investors
Press Releases Year None2019201820172016201520142013201220112010 Aug 09, 2019 Assembly Biosciences Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) View HTML PDF Version Aug 07, 2019 Assembly Biosciences Announces Appointment of John McHutchison, AO, MD, as President and Chief Executive Officer View HTML PDF Version Aug 05, 2019 Assembly Biosciences Reports Second Quarter 2019 Financial Results and Recent Highlights View HTML PDF Version Jun 27, 2019 Assembly Biosciences Announces First Patient Dosed with ABI-M201 in Phase 1b Clinical Trial for Mildly to Moderately Active Ulcerative Colitis View HTML PDF Version Jun 25, 2019 Assembly Biosciences Announces Participation in the Microbiome Movement Drug Development Summit View HTML PDF Version Jun 21, 2019 Assembly Biosciences Announces Presentation at International Association for the Study of the Liver Congress and Update on HBV Program in China View HTML PDF Version May 09, 2019 Assembly Biosciences Reports First Quarter 2019 Financial Results and Recent Highlights View HTML PDF Version May 02, 2019 Assembly Biosciences Announces Changes to Senior Leadership Team View HTML PDF Version Apr 22, 2019 Development Veteran Steven J. Knox Joins Assembly Biosciences as Senior Vice President, Clinical Development View HTML PDF Version Apr 13, 2019 Assembly Biosciences Presents Interim Data from Two Phase 2a Studies of ABI-H0731 in HBV-Infected Subjects in a Late-Breaker Oral Session at EASL 2019 View HTML PDF Version Pagination Current page 1 Page 2 Next page next › Last page last »
